The Leadership Team at Larimar Therapeutics is responsible for guiding the strategic direction and operational oversight of the company as it advances its innovative therapies for rare diseases. This team comprises key executives who collaborate to ensure regulatory compliance, financial stability, and clinical development success, while fostering a culture of innovation and accountability throughout the organization.
Carole Ben-Maimon
President & CEO
Jennifer Johansson
VP, Regulatory, Quality & Lega...
John Berman
VP of Finance & Administration
Keith E. Lynch, Jr.
VP, CMC Technical Operations
Michael Celano
Chief Financial Officer
Mohamed Hamdani
Vice President, Biometrics And...
Noreen Scherer
Vice President, Clinical Opera...
View all